首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Intracellular calcium activates TRPM2 and its alternative spliced isoforms
【24h】

Intracellular calcium activates TRPM2 and its alternative spliced isoforms

机译:细胞内钙激活TRPM2及其替代的剪接亚型

获取原文
获取原文并翻译 | 示例
       

摘要

Melastatin-related transient receptor potential channel 2 (TRPM2) is a Ca~(2+)-permeable, nonselective cation channel that is involved in oxidative stress-induced cell death and inflammation processes. Although TRPM2 can be activated by ADP-ribose (ADPR) in vitro, it was unknown how TRPM2 is gated in vivo. Moreover, several alternative spliced isoforms of TRPM2 identified recently are insensitive to ADPR, and their gating mechanisms remain unclear. Here, we report that intracellular Ca~(2+) ([Ca~(2+)]_i) can activate TRPM2 as well as its spliced isoforms. We demonstrate that TRPM2 mutants with disrupted ADPR-binding sites can be activated readily by [Ca~(2+)]_i, indicating that [Ca~(2+)]_i gating of TRPM2 is independent of ADPR. The mechanism by which [Ca~(2+)]_i activates TRPM2 is via a calmodulin (CaM)-binding domain in the N terminus of TRPM2. Whereas Ca~(2+)-mediated TRPM2 activation is independent of ADPR and ADPR-binding sites, both [Ca~(2+)]_i and the CaM-binding motif are required for ADPR-mediated TRPM2 gating. Importantly, we demonstrate that intracellular Ca~(2+) release activates both recombinant and endogenous TRPM2 in intact cells. Moreover, receptor activation-induced Ca~(2+) release is capable of activating TRPM2. These results indicate that [Ca~(2+)]_i is a key activator of TRPM2 and the only known activator of the spliced isoforms of TRPM2. Our findings suggest that [Ca~(2+)]_i-mediated activation of TRPM2 and its alternative spliced isoforms may represent a major gating mechanism in vivo, therefore conferring important physiological and pathological functions of TRPM2 and its spliced isoforms in response to elevation of [Ca~(2+)]_i.
机译:褪黑素相关的瞬时受体电位通道2(TRPM2)是可渗透Ca〜(2+)的非选择性阳离子通道,参与氧化应激诱导的细胞死亡和炎症过程。尽管TRPM2可以在体外被ADP-核糖(ADPR)激活,但还不知道TRPM2如何在体内被门控。此外,最近鉴定出的TRPM2的几种可变剪接异构体对ADPR不敏感,其门控机制仍不清楚。在这里,我们报道细胞内Ca〜(2+)([Ca〜(2 +)] _ i)可以激活TRPM2及其剪接的同工型。我们证明了具有破坏的ADPR结合位点的TRPM2突变体可以很容易地被[Ca〜(2 +)] _ i激活,表明TRPM2的[Ca〜(2 +)] _ i门控独立于ADPR。 [Ca〜(2 +)] _ i激活TRPM2的机制是通过TRPM2 N末端的钙调蛋白(CaM)结合域。 Ca〜(2+)介导的TRPM2激活与ADPR和ADPR结合位点无关,而[Ca〜(2 +)] _ i和CaM结合基序对于ADPR介导的TRPM2门控来说都是必需的。重要的是,我们证明细胞内Ca〜(2+)释放激活完整细胞中的重组和内源TRPM2。此外,受体激活诱导的Ca〜(2+)释放能够激活TRPM2。这些结果表明[Ca〜(2 +)] _ i是TRPM2的关键激活剂,也是TRPM2剪接同工型的唯一已知激活剂。我们的发现表明,[Ca〜(2 +)] _ i介导的TRPM2及其替代剪接异构体的激活可能代表体内的主要门控机制,因此赋予TRPM2及其剪接异构体重要的生理和病理功能,以响应于TPM2的升高。 [Ca〜(2 +)] _ i。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号